Moffitt Researchers Develop Tool to Measure Patient Health and Well-Being after Radionuclide Therapy
Moffitt Cancer CenterMoffitt Cancer Center researchers have developed a tool to determine how a new class of prostate cancer therapies called radionuclide therapy (RNT) impacts patient-reported outcomes with the goal of using this information to guide treatment and improve quality of care. Their findings have been published in The Journal of Nuclear Medicine.